Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	274.59B +11.9%
Revenue (ttm)	860.31B -0.9%
Net Income	12.85B -2.6%
EPS	614.00 -13.1%
Shares Out	21.97M
PE Ratio	20.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,665
Average Volume	74,071
Open	12,450
Previous Close	12,500
Day's Range	12,450 - 12,500
52-Week Range	9,990 - 12,600
Beta	0.40
RSI	72.98
Earnings Date	Jul 30, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 683
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2025, HOSE:DBT's revenue was 860.31 billion, a decrease of -0.93% compared to the previous year's 868.41 billion. Earnings were 12.85 billion, a decrease of -2.66%.